Jump to navigation Jump to search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Chlormezanone


Most recent articles on Chlormezanone

Most cited articles on Chlormezanone

Review articles on Chlormezanone

Articles on Chlormezanone in N Eng J Med, Lancet, BMJ


Powerpoint slides on Chlormezanone

Images of Chlormezanone

Photos of Chlormezanone

Podcasts & MP3s on Chlormezanone

Videos on Chlormezanone

Evidence Based Medicine

Cochrane Collaboration on Chlormezanone

Bandolier on Chlormezanone

TRIP on Chlormezanone

Clinical Trials

Ongoing Trials on Chlormezanone at Clinical

Trial results on Chlormezanone

Clinical Trials on Chlormezanone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Chlormezanone

NICE Guidance on Chlormezanone


FDA on Chlormezanone

CDC on Chlormezanone


Books on Chlormezanone


Chlormezanone in the news

Be alerted to news on Chlormezanone

News trends on Chlormezanone


Blogs on Chlormezanone


Definitions of Chlormezanone

Patient Resources / Community

Patient resources on Chlormezanone

Discussion groups on Chlormezanone

Patient Handouts on Chlormezanone

Directions to Hospitals Treating Chlormezanone

Risk calculators and risk factors for Chlormezanone

Healthcare Provider Resources

Symptoms of Chlormezanone

Causes & Risk Factors for Chlormezanone

Diagnostic studies for Chlormezanone

Treatment of Chlormezanone

Continuing Medical Education (CME)

CME Programs on Chlormezanone


Chlormezanone en Espanol

Chlormezanone en Francais


Chlormezanone in the Marketplace

Patents on Chlormezanone

Experimental / Informatics

List of terms related to Chlormezanone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Chlormezanone (marketed under the brandname Trancopal or Fenaprim) is a drug used as an anxiolytic and a muscle relaxant. Its use was discontinued in many countries from 1996 on, due to rare but serious cases of toxic epidermal necrolysis.


This image is provided by the National Library of Medicine.


  • Wollina U, Hipler U, Seeling A, Oelschlager H (2005). "Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro". Skin Pharmacol Physiol. 18 (3): 132–138. doi:10.1159/000084910. PMID 15897685.
  • Seeling A, Oelschläger H, Rothley D (2000). "Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone". Pharmazie. 55 (4): 293–6. PMID 10798243.
  • Oelschläger H, Klinger W, Rothley D, Seeling A, Bockhard H, Hofmann B, Machts H, Riederer H, Rackur H (1998). "[Cleavage and biotransformation of the central muscle relaxant chlormezanone]". Pharmazie. 53 (9): 620–4. PMID 9770210.
  • Gautier V, Vincon G, Demotes-Mainard F, Albin H (1990). "[Pharmacokinetics of chlormezanone in healthy volunteers] (original in French)". Pharmazie. 45 (4): 315–9. PMID 2399514.